Legal Representation
Attorney
STEVEN M. WEISS
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 9, 2005 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 9, 2005 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 8, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 8, 2004 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 8, 2004 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 23, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Mar 18, 2004 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 8, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 8, 2004 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 17, 2003 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 10, 2003 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 10, 2003 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 9, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 4, 2003 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 4, 2003 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 10, 2002 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 18, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 29, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jan 8, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 10, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 2, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Dec 7, 2000 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 6, 2000 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products, namely, DNA sequences for use in genotyping, biopolymer profiling, detecting diseases, determining the progression of diseases, and determining drug responses for clinical, medical or medical lab use; diagnostic medical reagents for medical use comprised primarily of reagents, processing chemicals, and solid matrix materials, for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, and cancer; diagnostic medical reagents for medical use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer; medical diagnostic test kits comprised primarily of reagents, processing chemicals, slides, patches, and solid matrix materials, for use in detecting pathogens in the environment
First Use Anywhere:
0
First Use in Commerce:
0
Class 009
DNA testing apparatus which carry or hold DNA samples for use in screening and characterizing such samples for medical/diagnostic/pharmacogenomic purposes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
009